Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIMERIX LIMITED Capital/Financing Update 2012

Dec 16, 2012

64804_rns_2012-12-16_705d216e-caf0-459d-a287-60e23723060b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [234 x 86] intentionally omitted <==

17 December 2012

The Manager Company Announcements Platform ASX Limited

SBN Rights Issue – Allotment of entitlement shares

Sun Biomedical Limited (ASX: SBN) advises that 34,203,174 fully paid, ordinary shares in the Company were allotted on 14 December 2012 pursuant to the Company’s fully underwritten, nonrenounceable rights issue announced on 9 November 2012. The shortfall securities are expected to be allotted by 21 December 2012.

The total number of shares in the Company on issue following the allotment of entitlement shares on 14 December 2012 is 199,773,178. The total number of shares on issue following allotment of shortfall securities will be 331,140,008.

Yours faithfully

==> picture [112 x 19] intentionally omitted <==

==> picture [112 x 19] intentionally omitted <==

Alfonso Grillo Company Secretary

Sun Biomedical Investor Communications Limited Computershare T: +61 1300 850 505 | F: +61 3 9473 2500

ASX:SBN www.sunbiomed.com

==> picture [66 x 6] intentionally omitted <==

----- Start of picture text ----- ABN 18 001 285 230----- End of picture text -----